Bio Pharma Dive
OCTOBER 13, 2020
The company did not disclose details, nor could it confirm whether the participant had received its shot. But J&J is now the second vaccine developer, along with AstraZeneca, to suspend testing for a safety review.
BioSpace
OCTOBER 13, 2020
Relief Therapeutics and NeuroRx released results on Tuesday from their open-label prospective study looking into RLF-100 (aviptadil) as a potential treatment for COVID-19 and respiratory failure.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 13, 2020
We observe that the COVID-19 crisis shines a light on the benefits to patients and industry stakeholders of bringing clinical trials closer to patients' homes.
pharmaphorum
OCTOBER 13, 2020
Ayming Group’s second annual International Innovation Barometer (IIB) has said that the international outlook for R&D is “remarkably promising” despite strong headwinds caused by COVID-19. The report reveals that R&D departments are being empowered by the creation of ‘innovation ecosystems’, new funding methods, and the deployment of technology.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
OCTOBER 13, 2020
The biotech won't be able to start human testing of an experimental Huntington's disease treatment until regulators see more manufacturing data.
BioSpace
OCTOBER 13, 2020
With multiple COVID-19 vaccines in development, the CDC is confident that any vaccines the FDA authorizes or approves will be safe because they are based on the FDA’s usual stringent protocols. The greater question, after a vaccine is approved, is how it will be distributed.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioPharma Reporter
OCTOBER 13, 2020
Roche plans to launch its high-volume Elecsys SARS-CoV-2 Antigen test at the end of 2020 in markets accepting the CE mark; while the company will file for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA).
Pharma Marketing Network
OCTOBER 13, 2020
Below is a Q&A with Mark Bard, Co-Founder of The DHC Group, who offers his insights on the challenges COVID-19 has brought to pharma, as well as what innovation is taking place due to this full shift to digital and what lies ahead in the future. What is the most challenging aspect of COVID-19 for the industry? Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for v
Drug Patent Watch
OCTOBER 13, 2020
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…. The post New patent for Astrazeneca Ab drug BYDUREON appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
OCTOBER 13, 2020
Credit: Egor Stadnichuk et al./Journal of Instrumentation Researchers from MIPT have developed a prototype detector of solar particles. The device is capable of picking up protons at kinetic energies between 10 and 100 megaelectronvolts, and electrons at 1-10 MeV. This covers most of the high-energy particle flux coming from the sun. The new detector can […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
OCTOBER 13, 2020
UK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen to spearhead the next stage in the company’s development into gene silencing and other areas. Since it was founded in 2001 the company has become one of the country’s best known biotechs thanks to its approach to designing drugs based around network biology. e-therapeutics aims to design drugs that work across several targets that drive complex diseases and its remit has ch
Scienmag
OCTOBER 13, 2020
Credit: Andreas Dietzel. A new study of the Great Barrier Reef shows populations of its small, medium and large corals have all declined in the past three decades. Lead author Dr Andy Dietzel, from the ARC Centre of Excellence for Coral Reef Studies (CoralCoE), says while there are numerous studies over centuries on the changes […].
Outsourcing Pharma
OCTOBER 13, 2020
The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial.
Scienmag
OCTOBER 13, 2020
The GCSAA Mendenhall Award Recognizes Academic Excellence Credit: Image courtesy UTIA. KNOXVILLE, Tenn. – The Golf Course Superintendents Association of America has presented the Mendenhall Award, the organization’s highest academic honor for undergraduate students, to Brinkley Mull, a senior in the Department of Plant Sciences at the UT Herbert College of Agriculture.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioSpace
OCTOBER 13, 2020
Scientists at the University of Pennsylvania hope to use powerful antimicrobial molecules found in the venom of the Vespula lewisii (Korean Yellow-jacket wasp) against the antibiotic-resistant bacteria that cause sepsis and tuberculosis.
Scienmag
OCTOBER 13, 2020
Recent advances in this field have made micro- and nanomotors promising devices for solving many biomedical problems Credit: CNIC/ IBEC A study by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), the Universidad Complutense (UCM), Universidad de Girona (UdG), and the Institute for Bioengineering of Catalonia (IBEC), working together with other international centers, has […].
Pharma Times
OCTOBER 13, 2020
In a letter to Health Secretary Matt Hancock the RPS called for urgent action
Scienmag
OCTOBER 13, 2020
Physicist, cancer researcher named fellow of International Association of Advanced Materials Credit: The University of Texas at Arlington The International Association of Advanced Materials (IAAM) has selected a physicist and renowned cancer researcher at The University of Texas at Arlington as a fellow in recognition of his original and significant research in the fields of […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharma Times
OCTOBER 13, 2020
Biologic therapy hit primary and all key secondary endpoints in phase III
Scienmag
OCTOBER 13, 2020
NCI-MATCH precision medicine trial makes major contributions to the use of tumor gene testing to select treatment for patients; new data has broad relevance in medicine and provides a roadmap for future precision medicine trials Credit: ECOG-ACRIN Cancer Research Group Five years ago, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and National Cancer Institute (NCI), part […].
Pharma Times
OCTOBER 13, 2020
The committee accepted a number of drugs through the PACE process
Scienmag
OCTOBER 13, 2020
Review papers provide an inventory of the greatest discoveries of the past decade and suggest targets for the next generation telescope Credit: Courtesy of Northern Arizona University NASA’s Spitzer Space Telescope, designed to study the early universe in infrared light, was the first telescope to see light from a planet outside our solar system.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioSpace
OCTOBER 13, 2020
In August, Nestlé gobbled up Aimmune in a $2.6 billion deal, and now the food allergy-focused company will serve as the point pharmaceutical business for Nestlé Health Science.
Scienmag
OCTOBER 13, 2020
The fully integrated program is the first of its kind in California Credit: UC Davis Health The UC Davis MIND Institute and the UC Davis Office of Diversity, Equity and Inclusion have received a $2.1 million grant from the U.S. Department of Education to create an inclusive, four-year college program for students with intellectual disabilities. […].
BioSpace
OCTOBER 13, 2020
The Beijing-based biotech will use the Series B funds to further their hematopoietic disease and cancer therapies pipeline and expand team.
Scienmag
OCTOBER 13, 2020
Study finds that compressing cells, and crowding their contents, can coax them to grow and divide Credit: Yiwei Li The closer people are physically to one another, the higher the chance for exchange, of things like ideas, information, and even infection. Now researchers at MIT and Boston Children’s Hospital have found that, even in the […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioSpace
OCTOBER 13, 2020
Dyno will be responsible for the design of the novel AAV capsids that are expected to have improved functional properties for gene therapy. Roche and its subsidiary Spark Therapeutics will take the capsids and conduct preclinical studies with hopes of taking them into the clinic, and eventually t.
Scienmag
OCTOBER 13, 2020
Advance planning, universal testing and connection with a medical center kept COVID-19 activity low in three facilities in new study Credit: University of Michigan Seven months ago, the nation first heard of a surge of COVID-19 deaths in a Washington nursing home – an early warning sign of how the coronavirus could rip through such […].
Drug Patent Watch
OCTOBER 13, 2020
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…. The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
OCTOBER 13, 2020
Venture capital firm Canaan Partners closed on a new fund, it’s twelfth, raising $800 million to invest.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
286 
Let's personalize your content